Vitalhub (TSE:VHI – Get Free Report) had its price target decreased by investment analysts at National Bank Financial from C$12.00 to C$10.00 in a research report issued on Monday, BayStreet reports. The firm presently has an “outperform” rating on the stock. National Bank Financial‘s price target suggests a potential upside of 53.37% from the company’s previous close.
Several other equities research analysts have also commented on VHI. TD cut their price objective on Vitalhub from C$13.00 to C$9.50 and set a “buy” rating for the company in a research note on Monday. Raymond James Financial decreased their target price on Vitalhub from C$11.00 to C$10.50 and set an “outperform” rating on the stock in a research report on Monday. Scotia lowered their price target on Vitalhub from C$12.00 to C$9.00 and set a “sector outperform” rating on the stock in a research note on Monday. Canaccord Genuity Group lowered their price target on Vitalhub from C$15.00 to C$14.50 and set a “buy” rating on the stock in a research note on Monday. Finally, ATB Cormark Capital Markets dropped their price target on Vitalhub from C$12.00 to C$10.25 and set an “outperform” rating for the company in a research report on Monday. Nine research analysts have rated the stock with a Buy rating. According to data from MarketBeat, Vitalhub presently has a consensus rating of “Buy” and an average price target of C$10.86.
Read Our Latest Stock Analysis on Vitalhub
Vitalhub Stock Performance
Shares of VHI traded down C$0.48 during mid-day trading on Monday, hitting C$6.52. 481,442 shares of the company were exchanged, compared to its average volume of 297,780. Vitalhub has a 1-year low of C$6.46 and a 1-year high of C$9.77. The company has a 50 day moving average of C$7.56 and a 200-day moving average of C$7.58. The stock has a market cap of C$412.97 million, a price-to-earnings ratio of 54.33, a price-to-earnings-growth ratio of 1.18 and a beta of 1.37.
Vitalhub (TSE:VHI – Get Free Report) last issued its quarterly earnings results on Thursday, November 12th. The company reported C$0.04 earnings per share for the quarter. Vitalhub had a net margin of 8.63% and a return on equity of 4.03%. The firm had revenue of C$31.91 million for the quarter. Research analysts anticipate that Vitalhub will post 0.23 earnings per share for the current fiscal year.
Vitalhub Company Profile
VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.
See Also
- Five stocks we like better than Vitalhub
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
